PAG returns to a historically fruitful niche with the acquisition of Japanese theme park operator Huis Ten Bosch. COVID-19 made the deal possible but remains a wildcard
Private equity firms are relying more heavily on Asia-based debt investors to support leveraged buyouts amid a loan logjam in the US, highlighting the region’s innovation and durability
Integral Corporation has launched a tender offer for Daiohs Corporation, a Tokyo-listed provider of office services – such as coffee machines and water dispensers as well as cleaning services – at a valuation of approximately JPY 20.2bn (USD 144m).
Orchestra Private Equity, which specialises in cross-border transactions involving Korea, Japan, and China, has acquired Japan-based scaffolding provider Stack for an undisclosed sum.
Australia-listed productivity software provider Nitro Software has rejected a AUD 386m (USD 263m) buyout offer from Potentia Capital and HarbourVest Partners.
Australia-based turnaround investor Anchorage Capital Partners has agreed to buy the New Zealand business of childcare provider Evolve Education for an enterprise value of NZD 46m (USD 28.1m).
PAG has agreed to buy Huis Ten Bosch, a Japanese theme park best known for its recreations of idyllic European cityscapes, for an equity valuation of approximately JPY 100bn (USD 722m).
Private equity investors are keen to acquire mature but unloved assets from Japanese corporates and reposition them for growth. Execution is seldom straightforward, and size often means complexity
Bain Capital has agreed to acquire Evident, a Japan-based medical devices manufacturer best known for producing microscopes, from Olympus Corporation for JPY 427.7bn (USD 3.08bn).
Dymon Asia Private Equity has agreed a carve-out of Singapore-based shipping industry equipment supplier RAM Spreaders from its German parent Salzgitter Maschinenbau for an undisclosed sum.
Australia-listed hospital operator Ramsay Health Care has rejected an alternative buyout proposal from a KKR-led consortium after progress with the initial bid was slowed by the need to conduct due diligence on Ramsay Santé, the company’s separate...
Keppel Corporation has purchased a majority interest in Singapore waste management services business 800 Super Holdings, which was delisted in 2019 through a KKR-backed take-private, at a valuation of SGD 380m (USD 273m).
Pacific Equity Partners (PEP) has acquired a majority stake in Altus Group, which claims to be Australia’s largest provider of traffic management services.
Nominations for the 2022 AVCJ Private Equity & Venture Capital Awards have now closed. Many thanks to all those who participated.
South Korean internet giant Kakao has abandoned plans to partially divest Kakao Mobility, its transportation division.
Ontario Teachers' Pension Plan (OTPP) has agreed its first control private equity buyout in India, taking a majority stake in Sahyadri Hospitals and setting up a partial exit for Everstone Group.
Having acquired Australian snacks producer The Arnott’s Group under its long-dated strategy, KKR hopes to make an enduring impact on sustainable sourcing and energy conservation
Thoma Bravo, which claims to be the largest private equity investor in software globally, has launched a AUD 1.05bn (USD 740m) take-private bid for Nearmap, a listed Australian provider of aerial imagery technology and location data.
Bain Capital has won board approval from Net Marketing, a Tokyo-listed online advertising and media management business, for a take-private that values the company at approximately JPY 13.6bn (USD 102m).
Singapore-based private equity firm Capital Square Partners is continuing its bid to privatise US-listed outsourced customer engagement platform StarTek, having revised its targeted valuation downwards in the wake of market volatility.
Australia’s Allegro Funds has made its first investment from its largest fund to date, flexing new capacity to invest at scale with petrol station chain Gull New Zealand
Genesis Capital, a mid-market Australian private equity firm specialising in healthcare, has acquired a majority stake in Crux Biolabs, a contract research organisation (CRO) based in the Melbourne suburbs.
Adamantem Capital has agreed to acquire Australia’s largest cardiology services provider through as a carve-out from KKR-backed healthcare giant GenesisCare.